The FDA Office of Oncologic Disease (OOD) in collaboration with the Oncology Center of Excellence (OCE) would like to share a new opportunity for recent graduates and postdoctoral trainees with interest in the area(s) of Pharmacoepidemiology, Data Science, Biostatistical, or Clinical Research.
Brief Description: The 21st Century Cures Act is designed to accelerate medical product development and bring new innovations and advances faster and more efficiently to the patients who need them. Under this Act, FDA must evaluate the use of real-world evidence (RWE) generated from real-world data (RWD) to modernize trial design and evidence development. Within the Oncology Center of Excellence (OCE), the newly established RWE Program has active opportunities to advance the use of RWD in OCE Scientific Priority Areas through collaborations with ongoing projects in Health Equity (specifically in understanding underrepresented groups), Special Populations (pediatrics, older adults, rare cancers), Immunotherapy, Patient-Focused Drug Development, and Precision Oncology. Under the guidance of a mentor, the participant will gain knowledge in scientific project management, research collaborations, methodologic approaches, patient focused drug development, genomics, regulatory science, clinical trials, and pharmacoepidemiology research, and RWE use for regulatory decision making.
Apply here. Applications are reviewed on a rolling basis.